ES2137509T3 - Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion. - Google Patents
Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion.Info
- Publication number
- ES2137509T3 ES2137509T3 ES95917216T ES95917216T ES2137509T3 ES 2137509 T3 ES2137509 T3 ES 2137509T3 ES 95917216 T ES95917216 T ES 95917216T ES 95917216 T ES95917216 T ES 95917216T ES 2137509 T3 ES2137509 T3 ES 2137509T3
- Authority
- ES
- Spain
- Prior art keywords
- procedures
- preparation
- elastase
- elastase inhibitors
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A COMPUESTOS QUE SON INHIBIDORES DE ELASTASA, EN CONCRETO ELASTASA NEUTROFILA HUMANA, Y A NUEVOS PROCESOS PARA FABRICAR LOS MISMOS. COMO INHIBIDORES DE ELASTASA NEUTROFILA HUMANA, LOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE UN PACIENTE AFECTADO CON UN TRASTORNO INFLAMATORIO NEUTROFILO ASOCIADO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25285794A | 1994-06-02 | 1994-06-02 | |
US32752094A | 1994-10-20 | 1994-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2137509T3 true ES2137509T3 (es) | 1999-12-16 |
Family
ID=26942742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95917216T Expired - Lifetime ES2137509T3 (es) | 1994-06-02 | 1995-05-01 | Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6008196A (es) |
EP (1) | EP0763055B1 (es) |
JP (1) | JP3721538B2 (es) |
KR (1) | KR100366328B1 (es) |
CN (1) | CN1152048C (es) |
AT (1) | ATE186305T1 (es) |
AU (1) | AU690986B2 (es) |
CA (1) | CA2189526C (es) |
DE (1) | DE69513167T2 (es) |
DK (1) | DK0763055T3 (es) |
ES (1) | ES2137509T3 (es) |
FI (1) | FI964789A0 (es) |
GR (1) | GR3032294T3 (es) |
HU (1) | HU221311B1 (es) |
IL (1) | IL113941A (es) |
NO (1) | NO316706B1 (es) |
NZ (1) | NZ284766A (es) |
TW (1) | TW376388B (es) |
WO (1) | WO1995033762A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
EP0763055B1 (en) * | 1994-06-02 | 1999-11-03 | Merrell Pharmaceuticals Inc. | Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
DE69522940T2 (de) * | 1994-06-02 | 2002-04-04 | Merrell Pharma Inc | Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren |
US6015791A (en) * | 1994-11-21 | 2000-01-18 | Cortech Inc. | Serine protease inhibitors-cycloheptane derivatives |
US6001811A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors--N-substituted derivatives |
US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
US6100238A (en) * | 1994-11-21 | 2000-08-08 | Cortech Inc. | Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors |
US6001813A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Val-pro containing α-keto oxadiazoles as serine protease inhibitors |
US6001814A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors |
US6150334A (en) * | 1994-11-21 | 2000-11-21 | Cortech, Inc. | Serine protease inhibitors-tripeptoid analogs |
US6159938A (en) * | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
US20020119985A1 (en) | 1994-11-21 | 2002-08-29 | Albert Gyorkos | Serine protease inhibitors |
US5998379A (en) * | 1994-11-21 | 1999-12-07 | Cortech Inc. | Serine protease inhibitors-proline analogs |
US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
NZ336046A (en) * | 1996-12-06 | 2000-10-27 | Cortech Inc | Serine protease inhibitors containing substituted oxadiazole, thiadiazole and triazole peptide derivatives |
US6656910B2 (en) | 1997-12-04 | 2003-12-02 | Cortech, Inc. | Serine protease inhibitors |
WO1999062538A1 (en) | 1998-06-03 | 1999-12-09 | Cortech Inc. | Alpha-keto oxadiazoles as serine protease inhibitors |
WO2000051624A2 (en) * | 1999-03-05 | 2000-09-08 | The Trustees Of University Technology Corporation | Methods and compositions useful in inhibiting apoptosis |
AU2003223718B2 (en) * | 2002-04-25 | 2007-08-16 | The Scripps Research Institute | Treatment and prevention of pulmonary conditions |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
ATE477020T1 (de) | 2002-06-07 | 2010-08-15 | Dyax Corp | Prevention und verringerung von ischemia |
CA2537113A1 (en) * | 2003-08-29 | 2005-03-10 | Dyax Corp. | Modified protease inhibitors |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
HUE038243T2 (hu) * | 2005-12-29 | 2018-10-29 | Dyax Corp | Proteáz gátlás |
EP2195010A4 (en) * | 2007-08-21 | 2012-03-14 | Genzyme Corp | TREATMENT WITH INHIBITORS OF KALLIKREINE |
EP2385843A4 (en) * | 2009-01-06 | 2013-02-27 | Dyax Corp | TREATMENT OF MUZOSITIS WITH CALLICINE INHIBITORS |
CA3168591A1 (en) | 2010-01-06 | 2011-07-14 | Takeda Pharmaceutical Company Limited | Plasma kallikrein binding proteins |
JP2014506257A (ja) | 2011-01-06 | 2014-03-13 | ダイアックス コーポレーション | 血漿カリクレイン結合タンパク質 |
KR102555955B1 (ko) | 2014-03-27 | 2023-07-18 | 다케다 파머수티컬 컴패니 리미티드 | 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법 |
EP3387018A1 (en) | 2015-12-11 | 2018-10-17 | Dyax Corp. | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
KR20220079527A (ko) | 2019-09-17 | 2022-06-13 | 메레오 바이오파마 4 리미티드 | 이식편 거부반응, 폐쇄성 세기관지염 증후군 및 이식편 대 숙주병의 치료에 사용하기 위한 알베레스타트 |
IL297211A (en) | 2020-04-16 | 2022-12-01 | Mereo Biopharma 4 Ltd | Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency |
AU2022373971A1 (en) | 2021-10-20 | 2024-04-04 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
US4277395A (en) * | 1980-06-16 | 1981-07-07 | Richardson-Merrell Inc. | Novel enzyme inhibitors |
US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
DE3324534A1 (de) * | 1983-07-07 | 1985-01-17 | Ciba-Geigy Ag, Basel | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
CA1267499A (en) * | 1983-07-12 | 1990-04-03 | Cedric H. Hassall | Peptide amides and aldehydes |
US4629724A (en) * | 1984-12-03 | 1986-12-16 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitors |
US4643991A (en) * | 1984-12-18 | 1987-02-17 | The University Of Kentucky Research Foundation | Peptide elastase inhibitors and methods |
US5055450A (en) * | 1985-01-22 | 1991-10-08 | Ici Americas Inc. | Peptide derivatives |
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
US5496927A (en) * | 1985-02-04 | 1996-03-05 | Merrell Pharmaceuticals Inc. | Peptidase inhibitors |
AU600226B2 (en) * | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
EP0204571B1 (en) * | 1985-06-07 | 1992-01-22 | Ici Americas Inc. | Selected difluoro derivatives |
GB8613703D0 (en) * | 1986-06-05 | 1986-07-09 | Ici America Inc | Difluoro peptide compounds |
US4935405A (en) * | 1986-10-31 | 1990-06-19 | Pfizer Inc. | Nor-statine and nor-cyclostatine polypeptides |
US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
EP0318318A1 (en) * | 1987-11-27 | 1989-05-31 | Sensititre Limited | Urine assay process and kit |
US5162307A (en) * | 1988-09-09 | 1992-11-10 | Board Of Trustees Of The University Of Kentucky | Polymer bound elastase inhibitors |
EP0371179A1 (en) * | 1988-10-28 | 1990-06-06 | Merrell Dow Pharmaceuticals Inc. | Novel analogs of peptidase substrates |
EP0369391A3 (en) * | 1988-11-15 | 1991-09-25 | Boehringer Ingelheim Pharmaceuticals Inc. | N-substituted amides |
CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
US5221665A (en) * | 1989-10-27 | 1993-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | N-substituted amides |
CA2077665A1 (en) * | 1990-03-05 | 1991-09-06 | Robert Siman | Chymotrypsin-like proteases and their inhibitors |
EP0480044A4 (en) * | 1990-03-30 | 1993-06-09 | Japan Tobacco Inc. | Novel 4h-3,1-benzoxazin-4-one derivative |
CA2098702A1 (en) * | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
US5296591A (en) * | 1990-12-31 | 1994-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
CA2105304C (en) * | 1991-03-01 | 2005-10-04 | Arthur C. Ley | Inhibitors of human neutrophil elastase and human cathepsin g |
WO1992020357A1 (en) * | 1991-05-23 | 1992-11-26 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
AU655831B2 (en) * | 1991-08-22 | 1995-01-12 | Merrell Pharmaceuticals Inc. | Novel orally-active elastase inhibitors |
US5478811A (en) * | 1991-08-22 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | Orally-active elastase inhibitors |
EP0721449B1 (en) * | 1993-10-01 | 2001-12-19 | Merrell Pharmaceuticals Inc. | Inhibitors of beta-amyloid protein production |
EP0763055B1 (en) * | 1994-06-02 | 1999-11-03 | Merrell Pharmaceuticals Inc. | Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
DE69522940T2 (de) * | 1994-06-02 | 2002-04-04 | Merrell Pharma Inc | Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren |
ATE246708T1 (de) * | 1994-06-02 | 2003-08-15 | Aventis Pharma Inc | Elatase-inhibitoren |
-
1995
- 1995-05-01 EP EP95917216A patent/EP0763055B1/en not_active Expired - Lifetime
- 1995-05-01 CA CA002189526A patent/CA2189526C/en not_active Expired - Lifetime
- 1995-05-01 US US08/737,905 patent/US6008196A/en not_active Expired - Lifetime
- 1995-05-01 AU AU24000/95A patent/AU690986B2/en not_active Ceased
- 1995-05-01 DE DE69513167T patent/DE69513167T2/de not_active Expired - Lifetime
- 1995-05-01 KR KR1019960706819A patent/KR100366328B1/ko not_active IP Right Cessation
- 1995-05-01 HU HU9603311A patent/HU221311B1/hu not_active IP Right Cessation
- 1995-05-01 ES ES95917216T patent/ES2137509T3/es not_active Expired - Lifetime
- 1995-05-01 DK DK95917216T patent/DK0763055T3/da active
- 1995-05-01 NZ NZ284766A patent/NZ284766A/en unknown
- 1995-05-01 AT AT95917216T patent/ATE186305T1/de not_active IP Right Cessation
- 1995-05-01 CN CNB951933760A patent/CN1152048C/zh not_active Expired - Fee Related
- 1995-05-01 JP JP50086096A patent/JP3721538B2/ja not_active Expired - Lifetime
- 1995-05-01 WO PCT/US1995/005363 patent/WO1995033762A1/en active IP Right Grant
- 1995-05-31 IL IL11394195A patent/IL113941A/xx not_active IP Right Cessation
- 1995-06-01 TW TW084105552A patent/TW376388B/zh active
-
1996
- 1996-11-29 FI FI964789A patent/FI964789A0/fi not_active IP Right Cessation
- 1996-11-29 NO NO19965098A patent/NO316706B1/no unknown
-
1999
- 1999-12-30 GR GR990403382T patent/GR3032294T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69513167T2 (de) | 2000-06-15 |
FI964789A (fi) | 1996-11-29 |
EP0763055B1 (en) | 1999-11-03 |
NO965098L (no) | 1997-01-31 |
DE69513167D1 (de) | 1999-12-09 |
FI964789A0 (fi) | 1996-11-29 |
US6008196A (en) | 1999-12-28 |
HU221311B1 (en) | 2002-09-28 |
EP0763055A1 (en) | 1997-03-19 |
MX9606031A (es) | 1998-05-31 |
HU9603311D0 (en) | 1997-01-28 |
NO316706B1 (no) | 2004-04-13 |
IL113941A (en) | 2000-02-17 |
KR100366328B1 (ko) | 2003-03-06 |
HUT75318A (en) | 1997-05-28 |
NZ284766A (en) | 1998-06-26 |
IL113941A0 (en) | 1995-08-31 |
NO965098D0 (no) | 1996-11-29 |
CN1152048C (zh) | 2004-06-02 |
GR3032294T3 (en) | 2000-04-27 |
AU690986B2 (en) | 1998-05-07 |
CA2189526A1 (en) | 1995-12-14 |
WO1995033762A1 (en) | 1995-12-14 |
ATE186305T1 (de) | 1999-11-15 |
CN1149876A (zh) | 1997-05-14 |
JPH10501529A (ja) | 1998-02-10 |
DK0763055T3 (da) | 2000-05-08 |
JP3721538B2 (ja) | 2005-11-30 |
TW376388B (en) | 1999-12-11 |
AU2400095A (en) | 1996-01-04 |
CA2189526C (en) | 2001-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2137509T3 (es) | Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion. | |
ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
ES2183937T3 (es) | Inhibidores de la adhesion celular. | |
SV1999000016A (es) | Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv | |
CO4340688A1 (es) | Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos. | |
ES2181614T3 (es) | Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. | |
AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
SV1999000009A (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol ref. pg3388/sv | |
SV2002000293A (es) | Compuestos indazole, composiciones farmaceuticas, y metodos para mediar o inhibir la proliferacion celular caso no. 0092-01-sv | |
PA8541601A1 (es) | Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7. | |
CR7716A (es) | Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor | |
GT199800158AA (es) | Agonistas de prostaglandinas y su uso para tratar trastornos oseos | |
ES2191152T3 (es) | Terapia combinada para el tratamiento de psicosis. | |
HN2003000182A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metodo para su uso | |
ES2124461T3 (es) | Derivados de oxalilamino-benzofurano y de benzotienilo. | |
ES2039269T5 (es) | Derivados de azolilmetil-ciclopropilo. | |
BR0114978A (pt) | Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares | |
DK464581A (da) | Ectoparasiticidholdige polyrethanhalsbaand til husdyr deres fremstilling og anvendelse | |
AR018201A1 (es) | Compuesto de mesilato de n-(3-etinilfenil)-6,7-bis-(2-metoxietoxi)-4-quinazolinamina, composiciones que los contienen y su uso de dichos compuestos para la preparacion de medicamentos. | |
ES238038Y (es) | Zapata de guía para camarines y similares de ascensores. | |
MX9307974A (es) | Nuevos derivados de acido hidroxiiminoalquilindolcarboxilico, su obtencion y uso. | |
HN2003000080A (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso | |
PA8555501A1 (es) | Compuestos de benzimidazol sustituido y su uso para el tratamiento del cancer | |
DK1895017T3 (da) | Anvendelse af A33-antigener og JAM-IT | |
ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 763055 Country of ref document: ES |